In addition, several of the CYP2B6-produced 9- and 13-position oxylipins are PPARα and PPARγ activators, providing a putative mechanism for CYP2B6 as an anti-obesity enzyme. This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.